The incidence of prostate cancer is 25 times higher in Australia and New Zealand then in South-Central Asia
Source: GLOBOCAN 2008 http://globocan.iarc.fr
Prostate cancer is the second most common cancer in men worldwide. Around 910 000 cases of prostate cancer were recorded in 2008, accounting for around 14 per cent of all new cancer cases in men. It is predicted that the number of cases will almost double (1.7 million) by 2030.
Incidence rates for prostate cancer were highest in Australia/New Zealand, Western and Northern Europe and North America and lowest in Asia. Within Africa the highest rate was in South Africa and the lowest in Northern Africa. In Europe the highest rates were in Western and Northern Europe, and the lowest rates were in Central and Eastern Europe.
Incidence rates for prostate cancer have increased in recent years. This has been largely due to the increased availability of screening for prostate-specific antigen (PSA) in men without symptoms of the disease. The test detects many prostate cancers that are small and /or would otherwise remained unrecognised and which may or may not develop further into higher stage disease. One reason for the high rate in some countries is the frequent use of PSA testing.
Age standardised incidence rates for prostate cancer 2008